We are live on ! Find out more
SGMO

SANGAMO THERAPEUTICS INC

Delisted

SGMO was delisted on the 4th of May, 2026.

193 hedge funds and large institutions have $657M invested in SANGAMO THERAPEUTICS INC in 2019 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 56 increasing their positions, 56 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

78% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 18

5% more funds holding

Funds holding: 184193 (+9)

0% more repeat investments, than reductions

Existing positions increased: 56 | Existing positions reduced: 56

3.29% less ownership

Funds ownership: 70.98%67.7% (-3.3%)

12% less capital invested

Capital invested by funds: $744M → $657M (-$87.2M)

21% less call options, than puts

Call options by funds: $10.5M | Put options by funds: $13.4M

Holders
193
Holders Change
+9
Holders Change %
+4.89%
% of All Funds
3.8%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
32
Increased
56
Reduced
56
Closed
18
Calls
$10.5M
Puts
$13.4M
Net Calls
-$2.85M
Net Calls Change
-$5.66M
Name Holding Trade Value Shares
Change
Change in
Stake
Susquehanna International Group
26
Susquehanna International Group
Pennsylvania
$5.1M -$197K -21,470 -3%
CS
27
Candriam SCA
Luxembourg
$4.35M -$874K -95,000 -15%
Bank of New York Mellon
28
Bank of New York Mellon
New York
$4.26M -$28.4K -3,094 -0.6%
Two Sigma Investments
29
Two Sigma Investments
New York
$3.94M +$2.85M +310,214 +193%
Creative Planning
30
Creative Planning
Kansas
$3.67M +$3.68M +400,553 +1,059%
AGA
31
Altrinsic Global Advisors
Connecticut
$3.49M
AG
32
Artal Group
Luxembourg
$3.39M
Macquarie Group
33
Macquarie Group
Australia
$3.35M
BNP Paribas Financial Markets
34
BNP Paribas Financial Markets
France
$3.33M +$3.48M +378,522 +1,988%
Marshall Wace
35
Marshall Wace
United Kingdom
$2.76M +$2.73M +296,968 +918%
Nordea Investment Management
36
Nordea Investment Management
Sweden
$2.63M +$153K +16,609 +6%
IBT
37
International Biotechnology Trust
United Kingdom
$2.53M -$432K -47,000 -13%
JP Morgan Chase
38
JP Morgan Chase
New York
$2.52M +$1.78M +193,444 +179%
Hudson Bay Capital Management
39
Hudson Bay Capital Management
Connecticut
$2.18M +$736K +80,000 +44%
FCM
40
Frontier Capital Management
Massachusetts
$2.08M -$239K -25,949 -9%
California Public Employees Retirement System
41
California Public Employees Retirement System
California
$2M +$437K +47,500 +25%
Barclays
42
Barclays
United Kingdom
$1.96M +$180K +19,540 +9%
State of New Jersey Common Pension Fund D
43
State of New Jersey Common Pension Fund D
New Jersey
$1.9M +$2.09M +226,775 New
Swiss National Bank
44
Swiss National Bank
Switzerland
$1.85M +$46.9K +5,100 +2%
SGA
45
Sector Gamma AS
Norway
$1.77M -$368K -40,000 -16%
PIM
46
Platinum Investment Management
Australia
$1.64M +$255K +27,680 +16%
B
47
Bailard
California
$1.63M -$506K -55,000 -22%
PP
48
PDT Partners
New York
$1.48M -$500K -54,425 -24%
California State Teachers Retirement System (CalSTRS)
49
California State Teachers Retirement System (CalSTRS)
California
$1.46M -$46.8K -5,088 -3%
HAM
50
HHR Asset Management
New Jersey
$1.44M -$158K -17,200 -9%

SGMO Hedge Fund Activity: Q4 2019 in Review

193 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in SANGAMO THERAPEUTICS INC (SGMO) for Q4 2019, worth a combined $657M — down 12% from $744M a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new SGMO positions and 18 closed out — a net gain of 14 holders — while 56 added to existing stakes and 56 trimmed.

The largest buyer was Pictet Asset Management (UK), adding an estimated $6.58M. The largest seller was Wellington Management Group, cutting an estimated $28.8M.

  • 193 institutional investors held SANGAMO THERAPEUTICS INC (SGMO) as of Q4 2019, up from 184 in Q3 2019.
  • Funds reported $657M of SANGAMO THERAPEUTICS INC stock for Q4 2019, down 12% quarter-over-quarter.
  • 32 funds opened new SANGAMO THERAPEUTICS INC positions in Q4 2019 and 18 closed out, a net change of +14 holders.
  • The largest SANGAMO THERAPEUTICS INC buyer in Q4 2019 was Pictet Asset Management (UK), an estimated $6.58M added.
  • The largest SANGAMO THERAPEUTICS INC seller in Q4 2019 was Wellington Management Group, an estimated $28.8M sold.

Based on aggregated 13F filings for Q4 2019.